These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2408062

  • 1. The use of cultured bone marrow cells in autologous transplantation.
    Coutinho LH, Testa NG, Chang J, Morgenstern G, Harrison C, Dexter TM.
    Prog Clin Biol Res; 1990; 333():415-32; discussion 433. PubMed ID: 2408062
    [Abstract] [Full Text] [Related]

  • 2. Autologous bone marrow transplantation for leukemia.
    Stuart RK.
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [Abstract] [Full Text] [Related]

  • 3. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J, Wu B, Liu Q, Feng R, Liu X, Meng F, Zhou S.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [Abstract] [Full Text] [Related]

  • 4. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D, Labar B, Bogdanic V, Skodlar J, Petrovecki M, Mrsic M, Maravic N, Sneller V, Radman I, Kovacevic-Metelko J.
    Wien Med Wochenschr; 1995 Aug; 145(2-3):61-4. PubMed ID: 7762256
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G, Hernandez A, Heyll A, Wolf HH, Wernet P.
    Cancer Detect Prev; 1996 Aug; 20(6):601-9. PubMed ID: 8939346
    [Abstract] [Full Text] [Related]

  • 11. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu T, Reiffers J, Goldman JM, Apperley J, Gratwohl A.
    Bone Marrow Transplant; 1997 Oct; 20(7):553-60. PubMed ID: 9337056
    [Abstract] [Full Text] [Related]

  • 12. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S, Barnett L, Heller G.
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [Abstract] [Full Text] [Related]

  • 13. Residual Ph- cells in chronic myeloid leukemia: detection and usefulness.
    Chang J, Coutinho LH, Santos AM, Brereton M, Harrison CJ, Testa NG.
    Stem Cells; 1993 May; 11 Suppl 1():59-61. PubMed ID: 8318920
    [Abstract] [Full Text] [Related]

  • 14. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Cottafavi L, Dotti GP, Rizzoli V.
    Bone Marrow Transplant; 1994 Sep; 14(3):425-32. PubMed ID: 7994267
    [Abstract] [Full Text] [Related]

  • 15. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
    Meloni G, Russo D, Baccarani M, Testoni N, Martinelli G, Fanin R, Zuffa E, Rosti G, Alimena G, Saglio G, Mandelli F, Tura S.
    Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors.
    Verma UN, Bagg A, Brown E, Mazumder A.
    Bone Marrow Transplant; 1994 Feb; 13(2):115-23. PubMed ID: 8205079
    [Abstract] [Full Text] [Related]

  • 17. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
    Chang J, Morgenstern GR, Coutinho LH, Scarffe JH, Carr T, Deakin DP, Testa NG, Dexter TM.
    Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase.
    Meloni G, De Fabritiis P, Alimena G, Malagnino F, Montefusco E, Sandrelli A, Pinto R, Vignetti M, Lo Coco F, Mandelli F.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():92-4. PubMed ID: 2576389
    [Abstract] [Full Text] [Related]

  • 20. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.